Orion Market Research
Global Scopolamine Market, Size, Share, Analysis
Report & Forecast to 2026
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
The scopolamine market is expected to grow at a CAGR of around 4.5% during the forecast period.
Scopolamine is also known as Hyoscine that is majorly used to treat motion sickness & nausea and
vomiting. It is an alkaloid drug that is extracted from the henbane plant. It is also used as a sedative and
can be used along with the morphine to relieve pain. The drug requires a prescription and is not available
as an over the counter drug.
Rise in the number of people suffering from stress and anxiety disorder is a major factor for the growth
of the scopolamine drug market. Moreover, significant research in the field of Alzheimer's disease
treatment is also undergoing related scopolamine which can provide a significant opportunity to the drug
if some positive results outcomes witnessed in the near future.
(Get 15% Discount on Buying this Report)
A full Report of Global Scopolamine Market is Available at: https://www.omrglobal.com/industry-
However, misuse of the drug for the illegal activities is one of the major challenge to the market as the
government may strict the regulations related to the distribution of the drug. When scopolamine is mixed
in the beverage of a person, it can cause a range of acute psychoses including hallucinations,
disorientation, and paranoia. As an estimate, around 50,000 cases of poisoning of scopolamine are
registered every year in the US and Colombia each. Moreover, the presence of alternative globally is a
restraining factor for the market. Ondansetron, Promethazine, Prochlorperazine are some of the
alternative drugs available in the market for the treatment of nause